London
· Delayed Price · Currency is GBP · Price in EUR Nicox Company Description
Nicox S.A. operates as an ophthalmology company in France and internationally.
The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial.
Nicox S.A. is developing NCX 4251, a novel patented ophthalmic suspension of fluticasone propionate nanocrystals that is in Phase 2b clinical trial for the treatment of dry eye disease; and NCX 1728, an NO-donating Phosphodiesterase-5 inhibitor, which is in preclinical evaluation.
In addition, the company offers VYZULTA, a latanoprostene bunod ophthalmic solution to treat patients with open-angle glaucoma or ocular hypertension; and ZERVIATE, a cetirizine ophthalmic solution for the treatment of ocular related associated with allergic conjunctivitis.
Nicox S.A. was founded in 1996 and is headquartered in Valbonne, France.
| Country | France |
| Founded | 1996 |
| Industry | Pharmaceutical Preparations |
| Employees | 28 |
| CEO | Gavin Spencer |
Contact Details
Address: Sundesk Sophia Antipolis Valbonne, 06410 France | |
| Phone | 33 4 97 24 53 00 |
| Website | nicox.com |
Stock Details
| Ticker Symbol | 0RCQ |
| Exchange | London Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Andreas Rutger Segerros M.B.A., M.Sc. | Chief Executive Officer |
| Dr. Michele Garufi Ph.D. | Co-Founder and Interim Chairman |
| Sandrine Gestin | Vice President of Finance |
| Doug Hubatsch | Chief Scientific Officer |
| Emmanuelle Pierry | General Counsel and Head of Legal Affairs |
| Dr. Gavin M. Spencer | Executive Vice President, Chief Business Officer and Head of Corporate Development |
| Dr. Ramesh Krishnamoorthy | Senior Director and Head of Late Stage CMC and Quality Control |
| Dr. Jose Boyer | Consultant |
| Dr. Ennio Ongini Ph.D. | Consultant |